A detailed history of Moore Capital Management, LP transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 88,259 shares of AVNS stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
88,259
Previous 53,447 65.13%
Holding current value
$1.01 Million
Previous $654,000 55.96%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$9.89 - $12.72 $344,290 - $442,808
34,812 Added 65.13%
88,259 $1.02 Million
Q2 2025

Aug 14, 2025

SELL
$12.03 - $14.52 $94,315 - $113,836
-7,840 Reduced 12.79%
53,447 $654,000
Q1 2025

May 15, 2025

BUY
$13.95 - $17.45 $337,827 - $422,586
24,217 Added 65.33%
61,287 $878,000
Q4 2024

Feb 14, 2025

BUY
$15.58 - $23.61 $577,550 - $875,222
37,070 New
37,070 $590,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $529M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.